Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | NQO2 | P16083 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ERN1 | O75460 | 1/20 | 0.44 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22627551 | 0.84 | ALDH1A1 (0.53) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL23077792 | 0.84 | MAPT (0.45) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL29450004 | 0.81 | MAPT (0.62) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL11038905 | 0.81 | MAPT (0.62) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL103601 | 0.81 | MAPT (0.62) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL382385 | 0.81 | MAPT (0.62) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL29364974 | 0.81 | MAPT (0.62) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| SCHEMBL11011451 | 0.78 | MAPT (0.59) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| Water SCHEMBL27864881 | 0.78 | MAPT (0.59) | MAPTALDH1A1CYP1A2KDM4EHPGD | |
| Ammonia Solution, Strong SCHEMBL27821564 | 0.78 | MAPT (0.59) | MAPTALDH1A1CYP1A2KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143086-A | type-I bioactive photosensitizer targeting histone deacetylase, preparation method and application | 上海市第一人民医院 | 2023-12-01 | — | — | CN | claimed |
| CN-108774183-A | A kind of preparation method of ethylene glycol compounds | 成都苑东生物制药股份有限公司 | 2018-11-09 | — | — | CN | claimed |
| WO-2007027460-A2 | ANTISKINNING COMPOUND AND COMPOSITIONS CONTAINING THEM | ARKEMA INC. (US) | 2007-03-08 | — | — | WO | claimed |
| US-20070044689-A1 | Antiskinning compound and compositions containing them | ARKEMA INC. | 2007-03-01 | — | — | US | claimed |
| EP-0939793-B1 | STABILIZATION OF BIOCIDAL ACTIVITY IN AIR DRYING ALKYDS | TROY TECHNOLOGY CORP INC (US) | 2001-10-10 | — | — | EP | claimed |
| US-5955483-A | HALOPROPARGYL AND CHELATE COMPOUND WITH TRANSITION METAL DRIER | TROY TECHNOLOGY CORPORATION (US) | 1999-09-21 | — | — | US | claimed |
| EP-0939793-A1 | STABILIZATION OF BIOCIDAL ACTIVITY IN AIR DRYING ALKYDS | TROY CORPORATION (US) | 1999-09-08 | — | — | EP | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| US-5916930-A | Stabilization of biocidal activity in air drying alkyds | TROY CORPORATION (US) | 1999-06-29 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998022543-A1 | STABILIZATION OF BIOCIDAL ACTIVITY IN AIR DRYING ALKYDS | TROY CORPORATION (US) | 1998-05-28 | — | — | WO | claimed |
| US-20230322803-A1 | SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | BRISTOL MYERS SQUIBB CO (US) | 2023-10-12 | — | — | US | disclosed |
| CN-116583509-A | Compounds and methods for treating cancer | 上海睿跃生物科技有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-11465960-B2 | Labile esters of agrochemicals for controlled release and reduction of off-site movement | MONSANTO TECHNOLOGY LLC (US) | 2022-10-11 | — | — | US | disclosed |
| US-20220048890-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. | 2022-02-17 | — | — | US | disclosed |
| US-5034530-A | For treatment of central nervous system problems such as convulsions and anxiety | NOVO NORDISK A/S (DK) | 1991-07-23 | — | — | US | disclosed |
| EP-0347094-A1 | Imidazoquinoxaline compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1989-12-20 | — | — | EP | disclosed |
| US-4870171-A | HYPOTENSIVE | TOYO JOZO KABUSHIKI KAISHA (JP) | 1989-09-26 | — | — | US | disclosed |
| EP-0304322-A1 | 1-Substituted alkyl-2-oxo-1,2-dihydroquinoxaline derivatives | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1989-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11465960-B2 | Labile esters of agrochemicals for controlled release and reduction of off-site movement | APEH, GUSB, CES2 | MAPT 2958/4885ALDH1A1 69/4885CYP1A2 39/4885 |
| US-20220048890-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING | RBM17, SF3B1, SF3B5 | MAPT 1932/4885ALDH1A1 3964/4885CYP1A2 4477/4885 |
| US-20230322803-A1 | SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER | DDX21, HRAS, RPL17 | MAPT 3829/4885ALDH1A1 1946/4885CYP1A2 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.